While CEA vaccines have been utilized in advanced CRC, they have yet to be studied in the prevention arena; thus, our study warrants a large cohort analysis of vaccination and prevention measures in high-risk populations of patients with colon adenomas that have aberrant TGF-β signaling concurrent with overexpression of CEA. The gene discussed is TGFB1; the disease is colorectal carcinoma.